Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1386594

registered interest
date	09/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reassure people experiencing symptoms of heart valve disease that they will have access to a face to face GP appointment during the covid-19 booster vaccine rollout.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	90402
answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>General practices will remain open but have been asked to prioritise vaccinations and emergency care for the rest of the year. General practitioners will still be able to refer patients with a heart condition to one of 40 new diagnostic centres to access detection and diagnostic checks closer to home.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 92141 question first answered 20/12/2021 10:29:28 answering member 4492 label Biography information for Maria Caulfield
tabling member	3960 label Biography information for Henry Smith

1383942

registered interest
date	01/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timescale is for HNS England's evaluation report on the performance of Rapid Diagnostic Centres.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	85238
answer	answer is ministerial correction date of answer 09/12/2021 answer text <p>Ipsos MORI, in collaboration with the Midlands and Lancashire Commissioning Support Unit and York Health Economics Consortium, have been commissioned to undertake a four year evaluation of the rapid diagnostic centre programme until the end of 2023/24. Throughout the evaluation, Ipsos MORI and their partners will produce quarterly and annual reports. The first annual report will be published shortly. The final report is due in March 2024.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 09/12/2021 13:51:18 answering member 4362 label Biography information for Edward Argar
tabling member	3960 label Biography information for Henry Smith

1382909

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of immunocompromised or immunosuppressed people have received (a) a Moderna third covid-19 vaccine dose and (b) the correct quantity of Moderna as a third dose.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83308
answer	answer is ministerial correction date of answer 10/01/2022 answer text <p>The information is not held in the format requested. Whilst data for Moderna vaccine administrations is collected, information by clinical risk groups is not held centrally.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 10/01/2022 12:44:07 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1382910

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunosuppression: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what measures are in place to ensure immunocompromised people’s covid-19 vaccine records are amended where third doses have been incorrectly recorded as boosters.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83309
answer	answer is ministerial correction date of answer 02/02/2022 answer text <p>For those who are severely immunosuppressed, the third primary COVID-19 vaccine dose is recorded as a booster vaccinations. A subsequent booster or fourth dose for eligible severely immunosuppressed patients after a further three months will be recorded as a second booster. Existing data systems support the recording of multiple boosters. All doses administered appear in an individual’s vaccination history and are recorded in the National Immunisation Management System and general practitioner record. An assessment determined that retrospectively updating or amending patient records in the immediate term could risk creating a data quality issue.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 83310 question first answered 02/02/2022 11:38:33 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1382911

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when covid-19 vaccine records will be amended to show third doses that have been incorrectly recorded as boosters.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83310
answer	answer is ministerial correction date of answer 02/02/2022 answer text <p>For those who are severely immunosuppressed, the third primary COVID-19 vaccine dose is recorded as a booster vaccinations. A subsequent booster or fourth dose for eligible severely immunosuppressed patients after a further three months will be recorded as a second booster. Existing data systems support the recording of multiple boosters. All doses administered appear in an individual’s vaccination history and are recorded in the National Immunisation Management System and general practitioner record. An assessment determined that retrospectively updating or amending patient records in the immediate term could risk creating a data quality issue.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 83309 question first answered 02/02/2022 11:38:33 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1382912

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Casirivimab/imdevimab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of the B.1.1.529 covid-19 variant on the (a) efficacy of Ronapreve and (b) efficacy of Ronapreve in immunocompromised people.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83311
answer	answer is ministerial correction date of answer 14/12/2021 answer text <p>The UK Health Security Agency have noted that B.1.1.529, or Omicron, could potentially have an impact on neutralising monoclonal antibody treatments. However, there is currently no confirmed evidence of reduced efficacy.</p><p>Regeneron is evaluating Ronapreve against the Omicron variant. Preliminary analyses from the company suggest that the antibodies in the cocktail may have the potential to retain activity against the Omicron variant, as well as the other existing variants of concern. Further in vitro data is expected over the next month.</p><p>On 17 September, Ronapreve was made available to treat the most vulnerable hospital patients in the United Kingdom through an interim clinical policy. This treatment will continue to be available this winter for hospitalised patients.</p><p>There will be ongoing monitoring (involving sample collection) of selected patients treated with nMABs (led by UK Health Security Agency). This will include monitoring the efficacy of the treatments against variants. The Therapeutics and Antivirals Taskforce will also keep the evidence under review, including how this could affect immunocompromised patients.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 14/12/2021 11:45:26 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1378075

registered interest
date	12/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to empower clinicians to prescribe medicinal cannabis; and if he will make a statement.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	73803
answer	answer is ministerial correction date of answer 18/11/2021 answer text <p>Whether to prescribe any medicine is a clinical decision and the Government has enabled the prescription of cannabis-based products for medicinal use where it is clinically appropriate. The Chief Medical Officer and NHS England have written to doctors and pharmacists to highlight the available guidance on the prescribing and use of unlicensed medicines and to clarify the procedure for prescribing and supplying cannabis-based products for medicinal use. Health Education England has also published an e-learning module on medicinal cannabis.</p><p>The licensed cannabis-based medicine Epidyolex is prescribed and routinely funded by the National Health Service for Dravet syndrome and Lennox-Gastaut syndrome. The Medicines and Healthcare products Regulatory Agency has recently approved Epidyolex for a third form of epilepsy and it is now being assessed by the National Institute for Health and Care Excellence (NICE) for this indication. The licensed medicine Sativex is also routinely funded to treat moderate to severe spasticity in adults with multiple sclerosis. On 6 September, NHS England issued a reminder to clinical commissioning groups of NICE’s guidance relating to Sativex and will be monitoring its uptake.</p><p>The latest NICE guidelines demonstrate a clear need for more evidence to support routine prescribing and funding decisions for unlicensed cannabis-based products on the NHS. The Government continues to support the establishment of clinical trials with NHS England and NHS Improvement and the National Institute for Health Research and from 1 April introduced a national patient registry to record patient outcomes. Since January 2020, the Refractory Epilepsy Specialist Clinical Advisory Service has been in place to provide advice and support for doctors to optimise the treatment of refractory epilepsy.</p><p> </p> answering member constituency Charnwood answering member printed Edward Argar grouped question UIN 73766 73767 73768 73769 question first answered 18/11/2021 10:20:44 answering member 4362 label Biography information for Edward Argar
tabling member	3960 label Biography information for Henry Smith

1365992

registered interest
date	03/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Casirivimab/imdevimab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people have been treated with Ronapreve for covid-19 (a) in each week and (b) in each clinical commissioning group area since that treatment became available; and how many of those recipients had blood cancer.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	69062
answer	answer is ministerial correction date of answer 06/12/2021 answer text <p>An interim clinical policy for Ronapreve (casirivimab and imdevimab) was published on 17 September 2021 and updated on 4 November. Since September 2021, over 1,200 patients in England have received this treatment.</p><p>NHS England and NHS Improvement collect information from trusts on usage based on the criteria set out in the policy for treatment of patients hospitalised due to COVID-19. The data collection is not designed to identify the number of such patients who have blood cancer. The information on the number of patients treated in each clinical commissioning group area and in each week is not currently available.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 06/12/2021 17:15:28 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1365993

registered interest
date	03/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many people (a) in total and (b) with blood cancer have received a third dose of their primary course of the covid-19 vaccination; and if he will publish that data on a daily basis.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	69063
answer	answer is ministerial correction date of answer 06/12/2021 answer text <p>The data requested is not available in the format requested. Daily data currently combines the total number of booster vaccinations and third primary doses, which is available at the following link:</p><p><a href="https://coronavirus.data.gov.uk/details/vaccinations" target="_blank">https://coronavirus.data.gov.uk/details/vaccinations</a></p><p>There are currently no plans to publish this data in a daily format. All individuals who have severe immunosuppression, including as a result of blood cancer, are eligible for their third primary dose of COVID-19 vaccine.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 06/12/2021 17:20:16 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1365994

registered interest
date	03/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunosuppression: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, which (a) Minister in his Department and (b) senior official in NHS England have specific responsibility for policy relating to people who are immunosuppressed during the outbreak of covid-19; and if he will make a statement.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	69064
answer	answer is ministerial correction date of answer 22/11/2021 answer text <p>I have responsibility for policy relating to people who are immunosuppressed during the COVID-19 outbreak. For NHS England and NHS Improvement, the Chief Executive has this responsibility.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 22/11/2021 16:59:28 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith